ClinicalTrials.Veeva

Menu

The TELEAP1 CPAP-telemonitoring Study

University Hospital Center (CHU) logo

University Hospital Center (CHU)

Status

Unknown

Conditions

Obstructive Sleep Apnea

Treatments

Other: SFRMS/SPLF CPAP-telemonitoring diagnosis/therapeutic algorithm.

Study type

Observational

Funder types

Other

Identifiers

NCT04897646
RECHMPL21_0082

Details and patient eligibility

About

TELEAP1 is a multicenter cohort pilot-study designed to evaluate the impact of a published SFRMS/SPLF CPAP-telemonitoring diagnosis/therapeutic algorithm on the CPAP-compliance of newly treated patients with obstructive sleep apnea..

Full description

Continuous Positive Airway Pressure (CPAP)-devices can track compliance, but also leaks and residual Apnea-Hypopnea-Index (AHIflow) values. CPAP tracking systems seem intuitively useful, but there are few data demonstrating the benefit of such systems in improving CPAP-compliance and/or patients quality of life.

In 2020, a working group from the Société Française de Recherche et de Médecine du Sommeil (SFRMS) and the Société de Pneumologie de Langue Française (SPLF) have proposed a CPAP-telemonitoring diagnosis/therapeutic algorithm for newly treated patients with obstructive sleep apnea.

In order to describe and evaluate the impact of this SFRMS/SPLF-algorithm (not only on the patient but also on the home care provider activity), a one year multicenter cohort pilot-study (TELAP1-study) was set up.

Enrollment

300 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 years of age or older
  • Patient newly CPAP-treated and eligible for care and for the reimbursement by the French Social Security rules
  • Signed informed consent

Exclusion criteria

  • Previous CPAP-treatment
  • Pregnancy
  • Inability to understand the nature and aims of the study or to communicate with the investigator
  • Simultaneous participation in another trial with an exclusion clause to participate in another trial
  • No affiliation with the French social security regime
  • Loss of personal capacity resulting in state protection
  • Deprivation of liberty by judicial or administrative decision

Trial contacts and locations

1

Loading...

Central trial contact

Arnaud Prigent, MD; Dany Jaffuel, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems